14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AMS vs TOI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
TOI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)
TOI Overall Winner
6-Pillar Tally: AMS 3 – 3 TOI
Matrix Metrics: AMS 5 – 5 TOI
As of Nov 16, 2026, The Oncology Institute, Inc. (TOI) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). AMS carries a Unified Composite Score of 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin), whereas TOI carries 53.5/100 (HOLD) at $5.13 (N/M Forward P/E, -4.4% operating margin).
Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile TOI trades in a Neutral technical trend (SURGE options phase, RSI 48.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TOI Moat ProfileCyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $506.9M market capitalization and -4.4% operating margin.
OpEx & R&D Reinvestment19.5% of Rev ($106M)
90D Engineering Disclosures0 Published
Investor FAQ AMS vs TOI Key Questions & Quantitative Answers
As of Nov 16, 2026, The Oncology Institute, Inc. (TOI) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). AMS carries a Unified Composite Score of 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin), whereas TOI carries 53.5/100 (HOLD) at $5.13 (N/M Forward P/E, -4.4% operating margin). Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile TOI trades in a Neutral technical trend (SURGE options phase, RSI 48.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TOI leads the Growth & Scale pillar: AMS posts +19.2% YoY revenue growth and -38.1% YoY earnings growth on $30M TTM revenue (34.8% gross margin, -7.4% operating margin), compared with TOI at +41.2% YoY revenue growth and +0.0% YoY earnings growth on $546M TTM revenue (15.1% gross margin, -4.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AMS cumulative revenue shifted +50.0% while TOI shifted +163.2%. In operating R&D and SG&A reinvestment, AMS deploys 42.2% of Rev ($13M) (0 90-day corporate R&D disclosures) versus 19.5% of Rev ($106M) (0 disclosures) for TOI.
AMS screens cheaper on headline valuation multiples. AMS trades at 44.6x Forward P/E, 44.6x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-3.0% FCF margin), whereas TOI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.0x EV/Revenue (-0.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMS (-12.1% ROE) versus TOI (-651.7% ROE) capital efficiency.
In options market volatility and institutional positioning, AMS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 46% Vol realized risk). By comparison, TOI carries 80.2% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (1.66β · 73% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.